Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.
Romero-Gómez M, Diago M, Andrade RJ, Calleja JL, Salmerón J, Fernández-Rodríguez CM, Solà R, García-Samaniego J, Herrerías JM, De la Mata M, Moreno-Otero R, Nuñez O, Olveira A, Durán S, Planas R; Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group. Romero-Gómez M, et al. Among authors: duran s. Hepatology. 2009 Dec;50(6):1702-8. doi: 10.1002/hep.23206. Hepatology. 2009. PMID: 19845037 Clinical Trial.
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH. Herz M, et al. Among authors: duran s. Clin Ther. 2003 Apr;25(4):1074-95. doi: 10.1016/s0149-2918(03)80068-1. Clin Ther. 2003. PMID: 12809958 Clinical Trial.
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021).
Arrieta F, Pedro-Botet J, Iglesias P, Obaya JC, Montanez L, Maldonado GF, Becerra A, Navarro J, Perez JC, Petrecca R, Pardo JL, Ribalta J, Sánchez-Margalet V, Duran S, Tébar FJ, Aguilar M. Arrieta F, et al. Among authors: duran s. Clin Investig Arterioscler. 2022 Jan-Feb;34(1):36-55. doi: 10.1016/j.arteri.2021.05.002. Epub 2021 Jul 28. Clin Investig Arterioscler. 2022. PMID: 34330545 English, Spanish.
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group. Mattoo V, et al. Among authors: duran s. Clin Ther. 2005 May;27(5):554-67. doi: 10.1016/j.clinthera.2005.05.005. Clin Ther. 2005. PMID: 15978304 Clinical Trial.
[Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)].
Arrieta F, Iglesias P, Pedro-Botet J, Tébar FJ, Ortega E, Nubiola A, Pardo JL, Maldonado GF, Obaya JC, Matute P, Petrecca R, Alonso N, Sarabia E, Sánchez-Margalet V, Alemán JJ, Navarro J, Becerra A, Duran S, Aguilar M, Escobar-Jiménez F; Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED). Arrieta F, et al. Among authors: duran s. Clin Investig Arterioscler. 2015 Jul-Aug;27(4):181-92. doi: 10.1016/j.arteri.2014.12.003. Epub 2015 Mar 29. Clin Investig Arterioscler. 2015. PMID: 25825221 Spanish.
[Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)].
Arrieta F, Iglesias P, Pedro-Botet J, Tébar FJ, Ortega E, Nubiola A, Pardo JL, Maldonado GF, Obaya JC, Matute P, Petrecca R, Alonso N, Sarabia E, Sánchez-Margalet V, Alemán JJ, Navarro J, Becerra A, Duran S, Aguilar M, Escobar-Jiménez F; Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED). Arrieta F, et al. Among authors: duran s. Aten Primaria. 2016 May;48(5):325-36. doi: 10.1016/j.aprim.2015.05.002. Epub 2015 May 29. Aten Primaria. 2016. PMID: 26031458 Free PMC article. Spanish.
Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).
Arrieta F, Iglesias P, Pedro-Botet J, Becerra A, Ortega E, Obaya JC, Nubiola A, Maldonado GF, Campos MDM, Petrecca R, Pardo JL, Sánchez-Margalet V, Alemán JJ, Navarro J, Duran S, Tébar FJ, Aguilar M, Escobar F; Grupo de Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED). Arrieta F, et al. Among authors: duran s. Clin Investig Arterioscler. 2018 May-Jun;30(3):137-153. doi: 10.1016/j.arteri.2018.03.002. Epub 2018 May 10. Clin Investig Arterioscler. 2018. PMID: 29754804 English, Spanish.
Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review.
Jiménez-Cortegana C, Iglesias P, Ribalta J, Vilariño-García T, Montañez L, Arrieta F, Aguilar M, Durán S, Obaya JC, Becerra A, Pedro-Botet J, Sánchez-Margalet V, On Behalf Of The Cardiovascular Disease Working Group Of The Spanish Society Of Diabetes Sed. Jiménez-Cortegana C, et al. Among authors: duran s. Nutrients. 2021 Nov 19;13(11):4150. doi: 10.3390/nu13114150. Nutrients. 2021. PMID: 34836405 Free PMC article. Review.
420 results